Plataforma BIOBADASER III

Registro Español de Acontecimientos Adversos de Terapias Biológicas en Enfermedades Reumáticas

Biobadaser Fase III

Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.

23/01/2008

Gomez-Reino JJ, Carmona L, Descalzo MA, Biobadaser Group.

Descargar documento

Arthritis Rheum, 2007;57(5):756-61